<DOC>
	<DOCNO>NCT01541176</DOCNO>
	<brief_summary>The main objective study demonstrate absence post-transplantation corticosteroid induce large increase renal graft fibrosis ( numerical reading ) biopsy one year post-transplantation immunosuppressive treatment strategy include standard oral corticosteroids.The secondary objective study consist compare various parameter ( fibrosis progression , renal function , dialysis , ratio proteinuria/creatinuria , acute rejection , donor-specific antibody , graft survival , clinical biological tolerance ) therapy corticosteroid post-transplantation comparison standard immunosuppressive treatment strategy include oral corticosteroid . Secondary objective study consist also compare two technique assess fibrosis numerical reading centralize blind read treatment group ( 2 anatomical pathologist ) .</brief_summary>
	<brief_title>Absence Steroid Renal Transplantation Digital Fibrosis Observation</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<criteria>Pre Adults age 18 to70 year , Accepting give , information , sign informed consent form , Not difficulty understand communicate investigator representative , Requiring renal transplant [ first second transplant ( except first renal transplant lose due rejection ) ] , Patient insure . Inclusion criterion : Transplant kidney decease live donor ( non HLAidentical ) ABO compatibility , Existence renal graft biopsy ( one graft , birenal transplant ) transplantation , Percentage positive response PRA ( panel reactive antibody ) , measure Luminex® le 20 % IgG antiT absence positive DSA Luminex regardless mean fluorescence ( MFI ) within last 6 month , Negative cross match T cytotoxicity / flow cytometry , Negative pregnancy test patient childbearing age , consent use effective contraception throughout study 6 week end study . First renal transplant lose due rejection , Combined transplantation , Previous history transplantation kidney , Non beat donor heart , Presence positive DSA Luminex® regardless average fluorescence ( MFI ) , Patients receive corticosteroid time transplantation , Necessity continue administration systemic immunosuppressive treatment transplantation , Infections severe diarrhea , vomit , upper gastrointestinal tract malabsorption active peptic ulcer , concomitant , significant uncontrolled , Subject HIV positive donor , Replicating viral hepatitis time randomization , Known allergy intolerance tacrolimus , macrolide , corticosteroid , mycophenolate mofetil excipients , Diagnosis de novo malignancy prior transplantation , exception treat effectively basal cell squamous cell carcinoma skin , Current participation another clinical study , All clinical condition investigator considers incompatible conduct study acceptable security condition , Inability patient comply study procedure , Pregnant breastfeed woman , Person place guardianship , protection law .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Corticotherapy</keyword>
	<keyword>Fibrosis</keyword>
	<keyword>Numerical reading</keyword>
	<keyword>18-70 year</keyword>
	<keyword>first renal transplant lose due rejection</keyword>
	<keyword>first second renal transplant</keyword>
</DOC>